S Buchbinder, J Kratzsch, G M Fiedler, V Yar, M Brügel, A Leichtle, W Weber, H Alexander, G Matthes, J Thiery
{"title":"体重和口服避孕药是血清CRP水平最重要的调节因子。","authors":"S Buchbinder, J Kratzsch, G M Fiedler, V Yar, M Brügel, A Leichtle, W Weber, H Alexander, G Matthes, J Thiery","doi":"10.1080/00365510701487727","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>C-reactive protein (CRP) levels are modulated by endogenous and exogenous factors independently of inflammation. The present study investigated the impact of oral contraceptives, endogenous oestrogens, age, gender, smoking, body mass index (BMI) and lipid levels on CRP concentrations in a healthy collective.</p><p><strong>Methods: </strong>Highly sensitive CRP, total cholesterol, HDL-cholesterol and LDL-cholesterol levels were measured in 850 blood donors (438 M, 412 F); 227 women in this group used oral contraceptive formulations (OC). Additionally, serum samples from 58 women undergoing in vitro fertilization cycles (IVF) were tested for CRP. Results. The 97.5th percentile of CRP levels of the blood donors was 4.91 mg/L in men, 7.52 mg/L in OC non-users and 11.95 mg/L in OC users. Overweight gives a 2-fold increase of median CRP levels in men and women. The combination of overweight and OC use in women resulted in 6-fold median CRP levels. Age, smoking and lipid levels were influencing factors of lower significance. In IVF patients the elevated oestradiol levels had no influence on CRP concentrations in multivariance analysis.</p><p><strong>Conclusion: </strong>The diagnostic and predictive value of CRP levels is most affected by BMI and oral contraceptive use, which suggests the need for further investigations into the role of CRP modulating factors in monitoring infectious diseases.</p>","PeriodicalId":501634,"journal":{"name":"Scandinavian Journal of Clinical and Laboratory Investigation","volume":" ","pages":"140-4"},"PeriodicalIF":0.0000,"publicationDate":"2008-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/00365510701487727","citationCount":"23","resultStr":"{\"title\":\"Body weight and oral contraceptives are the most important modulators of serum CRP levels.\",\"authors\":\"S Buchbinder, J Kratzsch, G M Fiedler, V Yar, M Brügel, A Leichtle, W Weber, H Alexander, G Matthes, J Thiery\",\"doi\":\"10.1080/00365510701487727\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>C-reactive protein (CRP) levels are modulated by endogenous and exogenous factors independently of inflammation. The present study investigated the impact of oral contraceptives, endogenous oestrogens, age, gender, smoking, body mass index (BMI) and lipid levels on CRP concentrations in a healthy collective.</p><p><strong>Methods: </strong>Highly sensitive CRP, total cholesterol, HDL-cholesterol and LDL-cholesterol levels were measured in 850 blood donors (438 M, 412 F); 227 women in this group used oral contraceptive formulations (OC). Additionally, serum samples from 58 women undergoing in vitro fertilization cycles (IVF) were tested for CRP. Results. The 97.5th percentile of CRP levels of the blood donors was 4.91 mg/L in men, 7.52 mg/L in OC non-users and 11.95 mg/L in OC users. Overweight gives a 2-fold increase of median CRP levels in men and women. The combination of overweight and OC use in women resulted in 6-fold median CRP levels. Age, smoking and lipid levels were influencing factors of lower significance. In IVF patients the elevated oestradiol levels had no influence on CRP concentrations in multivariance analysis.</p><p><strong>Conclusion: </strong>The diagnostic and predictive value of CRP levels is most affected by BMI and oral contraceptive use, which suggests the need for further investigations into the role of CRP modulating factors in monitoring infectious diseases.</p>\",\"PeriodicalId\":501634,\"journal\":{\"name\":\"Scandinavian Journal of Clinical and Laboratory Investigation\",\"volume\":\" \",\"pages\":\"140-4\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2008-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1080/00365510701487727\",\"citationCount\":\"23\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Scandinavian Journal of Clinical and Laboratory Investigation\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/00365510701487727\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2007/11/21 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Scandinavian Journal of Clinical and Laboratory Investigation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/00365510701487727","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2007/11/21 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 23
摘要
背景:c -反应蛋白(CRP)水平受内源性和外源性因素调节,独立于炎症。本研究调查了口服避孕药、内源性雌激素、年龄、性别、吸烟、体重指数(BMI)和脂质水平对健康人群CRP浓度的影响。方法:测定850例献血者(438 M, 412 F)的高敏感CRP、总胆固醇、高密度脂蛋白胆固醇和低密度脂蛋白胆固醇水平;该组227名妇女使用口服避孕药配方(OC)。此外,对58名接受体外受精周期(IVF)的妇女的血清样本进行CRP检测。结果。献血者CRP水平的97.5%,男性为4.91 mg/L,不使用OC者为7.52 mg/L,使用OC者为11.95 mg/L。超重会使男性和女性的中位数CRP水平增加2倍。在女性中,超重和使用OC的组合导致CRP水平中值的6倍。年龄、吸烟、血脂水平为影响因素,差异不显著。多方差分析显示,体外受精患者雌二醇水平升高对CRP浓度无影响。结论:CRP水平的诊断和预测价值受BMI和口服避孕药使用的影响最大,需要进一步研究CRP调节因子在感染性疾病监测中的作用。
Body weight and oral contraceptives are the most important modulators of serum CRP levels.
Background: C-reactive protein (CRP) levels are modulated by endogenous and exogenous factors independently of inflammation. The present study investigated the impact of oral contraceptives, endogenous oestrogens, age, gender, smoking, body mass index (BMI) and lipid levels on CRP concentrations in a healthy collective.
Methods: Highly sensitive CRP, total cholesterol, HDL-cholesterol and LDL-cholesterol levels were measured in 850 blood donors (438 M, 412 F); 227 women in this group used oral contraceptive formulations (OC). Additionally, serum samples from 58 women undergoing in vitro fertilization cycles (IVF) were tested for CRP. Results. The 97.5th percentile of CRP levels of the blood donors was 4.91 mg/L in men, 7.52 mg/L in OC non-users and 11.95 mg/L in OC users. Overweight gives a 2-fold increase of median CRP levels in men and women. The combination of overweight and OC use in women resulted in 6-fold median CRP levels. Age, smoking and lipid levels were influencing factors of lower significance. In IVF patients the elevated oestradiol levels had no influence on CRP concentrations in multivariance analysis.
Conclusion: The diagnostic and predictive value of CRP levels is most affected by BMI and oral contraceptive use, which suggests the need for further investigations into the role of CRP modulating factors in monitoring infectious diseases.